10-Q Filing

GLUCOSE HEALTH, INC. CIK: 1420108 Q2 2013

Filing Information

Form Type	10-Q
Accession Number	`0001477932-13-003445`
Period End Date	20130630
Filing Date	20130802
Fiscal Year	2013
Fiscal Period	Q2
XBRL Instance	bisu-20130630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 46 Income Statement 97 Cash Flow Statement 61

Balance Sheet 46 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	$16.51K	USD	Point-in-time
Cash	`Cash`	$1.08K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Inventory	`InventoryNet`	$43.90K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$60.42K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.08K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	101.09M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	156.94M	shares	Point-in-time
Intellectual Property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$431.60K	USD	Point-in-time
Intellectual Property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$206.60K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	156.94M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	101.09M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$207.68K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$492.02K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$112.32K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$123.20K	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	$12.25K	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	-	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	$1.60K	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	$1.64K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$108.49K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$60.68K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$234.70K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$185.48K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$185.48K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$234.70K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 156,943,593 and 101,085,862 shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively	`CommonStockValue`	$156.94K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 156,943,593 and 101,085,862 shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively	`CommonStockValue`	$101.09K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$3.59M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$4.38M	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	$-182.75K	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	$-150.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$568.65K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.15M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$22.20K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$257.32K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$207.68K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$492.02K	USD	Point-in-time

Income Statement 97 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`SalesRevenueGoodsNet`	-	USD	2 Qtrs
REVENUE	`SalesRevenueGoodsNet`	-	USD	2 Qtrs
REVENUE	`SalesRevenueGoodsNet`	-	USD	1 Quarter
REVENUE	`SalesRevenueGoodsNet`	-	USD	7 Qtrs
REVENUE	`SalesRevenueGoodsNet`	-	USD	1 Quarter
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	-	USD	1 Quarter
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	-	USD	1 Quarter
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	$3.63K	USD	7 Qtrs
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	-	USD	2 Qtrs
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	-	USD	2 Qtrs
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Total Cost of Revenues	`CostOfGoodsSold`	$3.63K	USD	7 Qtrs
Total Cost of Revenues	`CostOfGoodsSold`	-	USD	2 Qtrs
Total Cost of Revenues	`CostOfGoodsSold`	-	USD	1 Quarter
Total Cost of Revenues	`CostOfGoodsSold`	-	USD	2 Qtrs
Total Cost of Revenues	`CostOfGoodsSold`	-	USD	1 Quarter
GROSS PROFIT (LOSS)	`GrossProfit`	-	USD	2 Qtrs
GROSS PROFIT (LOSS)	`GrossProfit`	-	USD	2 Qtrs
GROSS PROFIT (LOSS)	`GrossProfit`	-	USD	1 Quarter
GROSS PROFIT (LOSS)	`GrossProfit`	-	USD	1 Quarter
GROSS PROFIT (LOSS)	`GrossProfit`	$-3.63K	USD	7 Qtrs
Professional fees/stock based compensation	`ShareBasedCompensation`	$282.22K	USD	1 Quarter
Professional fees/stock based compensation	`ShareBasedCompensation`	$18.09K	USD	1 Quarter
Professional fees/stock based compensation	`ShareBasedCompensation`	$902.76K	USD	7 Qtrs
Professional fees/stock based compensation	`ShareBasedCompensation`	$465.48K	USD	2 Qtrs
Professional fees/stock based compensation	`ShareBasedCompensation`	$23.77K	USD	2 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	1 Quarter
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	2 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	1 Quarter
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	2 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	$85.29K	USD	7 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$12.59K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.19K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.49K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.34K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$18.87K	USD	7 Qtrs
Total Operating Expenses	`OperatingExpenses`	$478.07K	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$21.27K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$285.57K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$28.25K	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$1.01M	USD	7 Qtrs
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-21.27K	USD	1 Quarter
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-1.01M	USD	7 Qtrs
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-478.07K	USD	2 Qtrs
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-285.57K	USD	1 Quarter
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-28.25K	USD	2 Qtrs
Interest expense	`InterestExpense`	$138.43K	USD	7 Qtrs
Interest expense	`InterestExpense`	$163.32K	USD	1 Quarter
Interest expense	`InterestExpense`	$102.26K	USD	2 Qtrs
Interest expense	`InterestExpense`	$59.07K	USD	1 Quarter
Interest expense	`InterestExpense`	$164.06K	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-164.06K	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-138.43K	USD	7 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-163.32K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-102.26K	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-59.07K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-184.60K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-344.63K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-192.31K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-1.15M	USD	7 Qtrs
NET LOSS	`NetIncomeLoss`	$-580.33K	USD	2 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	67.19M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	67.19M	shares	2 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	120.80M	shares	2 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	132.69M	shares	1 Quarter
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.00	USD	1 Quarter
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.00	USD	1 Quarter
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.00	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-184.60K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-344.63K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-192.31K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.15M	USD	7 Qtrs
Net loss	`NetIncomeLoss`	$-580.33K	USD	2 Qtrs
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-12.58K	USD	7 Qtrs
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	-	USD	2 Qtrs
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$6.58K	USD	1 Quarter
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$61.00	USD	2 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-192.25K	USD	2 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-1.16M	USD	7 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-344.63K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-178.02K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-580.33K	USD	2 Qtrs

Cash Flow Statement 61 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-184.60K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-344.63K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-192.31K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.15M	USD	7 Qtrs
Net loss	`NetIncomeLoss`	$-580.33K	USD	2 Qtrs
Impairment expense	`AssetImpairmentCharges`	-	USD	2 Qtrs
Impairment expense	`AssetImpairmentCharges`	$85.29K	USD	7 Qtrs
Impairment expense	`AssetImpairmentCharges`	-	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$780.66K	USD	7 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$428.30K	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	2 Qtrs
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-162.36K	USD	2 Qtrs
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-134.12K	USD	7 Qtrs
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-99.83K	USD	2 Qtrs
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	$43.90K	USD	7 Qtrs
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	-	USD	2 Qtrs
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	$43.90K	USD	2 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-3.68K	USD	2 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$5.93K	USD	7 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-2.08K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$158.67K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$482.14K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$962.10K	USD	7 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-98.19K	USD	2 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-33.64K	USD	2 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-186.88K	USD	7 Qtrs
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	$12.00K	USD	2 Qtrs
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	$10.61K	USD	7 Qtrs
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	2 Qtrs
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	$4.87K	USD	7 Qtrs
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	-	USD	2 Qtrs
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	-	USD	2 Qtrs
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$28.60K	USD	2 Qtrs
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$101.62K	USD	2 Qtrs
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$178.47K	USD	7 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$28.60K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$113.62K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$193.95K	USD	7 Qtrs
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$5.18K	USD	2 Qtrs
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	-	USD	2 Qtrs
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$5.51K	USD	7 Qtrs
NET INCREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$12.58K	USD	7 Qtrs
NET INCREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$15.44K	USD	2 Qtrs
NET INCREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$138.00	USD	2 Qtrs
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$82.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.93K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.08K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$220.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$16.51K	USD	Point-in-time
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$10.00K	USD	2 Qtrs
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$120.09K	USD	7 Qtrs
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$55.95K	USD	2 Qtrs
Conversion of liability to common stock	`StockIssued1`	$6.38K	USD	2 Qtrs
Conversion of liability to common stock	`StockIssued1`	$41.50K	USD	2 Qtrs
Conversion of liability to common stock	`StockIssued1`	$54.17K	USD	7 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	$231.60K	USD	7 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	-	USD	2 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	$225.00K	USD	2 Qtrs
Conversion of accounts payable and notes payable to equity (Note 7)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$217.81K	USD	2 Qtrs
Conversion of accounts payable and notes payable to equity (Note 7)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	2 Qtrs
Conversion of accounts payable and notes payable to equity (Note 7)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$291.56K	USD	7 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.